Heart disease in women

Primary Care - Clinics in Office Practice

Volumn 27, Issue 3, 2000, Pages 741-766

  Heim, Lori J ^a   Brunsell, Susan C ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN; FIBRINOLYTIC AGENT; HEPARIN; ORAL CONTRACEPTIVE AGENT; PHYTOESTROGEN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THIAZIDE DIURETIC AGENT;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE PERFUSION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033846286     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70172-X     Document Type: Article

References (102)

1. Homocysteine and cardiovascular disease
2. Dietary phytoestrogens and menopause in Japan
3. Effects of lifestyle activity vs structured aerobic exercise in obese women
4. Meta-analysis of the effects of soy protein intake on serum lipids
5. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in postmenopausal monkeys
6. Differences in the use of procedures between women and men hospitalized for coronary heart disease
7. Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel keys Lecture
8. Comparison of clinical outcomes for men and women after acute myocardial infarction
9. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
10. Obesity: A time bomb to be defused
11. Coronary heart disease risk factors in women
12. Aspirin and stroke
13. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women
14. Outcomes for older men and women with congestive heart failure
15. Sex-related differences in eligibility for reperfusion therapy and in-hospital outcome after acute myocardial infarction
16. Observations of the treatment of women in the United States with myocardial infarction
17. The national cholesterol education program: Progress and prospects
18. Menopause and the risk of coronary heart disease in women
19. Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease
20. Coronary heart disease mortality and adjuvant tamoxifen therapy
21. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women
22. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Research Group
23. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
24. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/Tex CAPS
25. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: A randomized trial
26. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration
27. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance
28. Differences between male and female patients with regard to baseline demographics and clinical outcomes in the Asymptomatic Cardiac Ischemia Pilot (ACIP) trial
29. A prospective study of alcohol consumption and mortality among women
30. The 25-year health care costs of women who remain overweight after 40 years of age
31. Hormone therapy to prevent disease and prolong life in postmenopausal women
32. In-hospital and 1-year mortality in 1524 women after myocardial infarction: Comparison with 4315 men
33. Postmenopausal hormone therapy and mortality
34. Diabetes and decline in heart disease mortality in US adults
35. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
36. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators
37. Delayed hospital presentation in patients who have had acute myocardial infarction
38. Gender considerations in hypertension payhophysiology and treatment
39. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomized trial
40. The Framingham Study
41. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women: The Strong Heart Study
42. Dietary fat intake and the risk of coronary heart disease in women
43. Body weight, weight change, and risk for hypertension in women
44. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
45. Better outcome for women compared with men undergoing coronary revascularization
46. Sex differences in the use of invasive coronary procedures in Ontario
47. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction
48. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
49. Gender differences in the management of acute chest pain: Support for the 'Yentl Syndrome'
50. Thiazide diuretics and fractures: Can meta-analysis help?
51. Sex differences in the features of coronary artery disease of patients undergoing coronary angiography
52. The treatment of hypertension in women
53. Heart failure in women
54. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women
55. Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS Study Group
56. Aspirin use and the incident stroke in the Cardiovascular Health Study
57. Triglycerides and coronary risk in women and the elderly
58. Effects of gender on cardiac arrhythmias
59. Underuse of cardiac procedures: Do women, ethnic minorities, and the uninsured fail to receive needed revascularization?
60. Neighborhood social context and racial differences in women's heart disease mortality
61. Unrecognized parozysmal supraventricular tachycardia: Potential for misdiagnosis as panic disorder
62. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease
63. Where are all the women with heart failure?
64. Mortality differences between men and women following first myocardial infarction
65. Influence of sex on the use of cardiac procedures in patients presenting to the emergency department
66. Gender differences in the treatment and outcome of acute myocardial infarction
67. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association
68. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
69. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women
70. Phytoestrogens: Natural hormone replacement therapy?
71. Smoking and risk of myocardial infarction in women and men: Longitudinal population study
72. Risk factors and the sex differential in coronary artery disease
73. Diagnostic testing for coronary artery disease in women and gender differences in referral for revascularization
74. Abdominal adiposity and coronary heart disease in women
75. Homocysteine and risk of cardiovascular disease among postmenopausal women
76. Folate and Vitamin B6 and coronary heart disease in women
77. Reporting of gender-related information in clinical trails of drug therapy for myocardial infarction
78. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
79. The effect of race and sex on physicians' recommendations for cardiac catheterization
80. Treatment and health outcomes of women and men in a cohort with artery disease
81. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease
82. Myocardial infarction in users of low-dose contraceptives
83. Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies
84. Diabetes mellitus and cardiovascular disease in women
85. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
86. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol
87. Sex differences in the management of coronary artery disease. Survival and ventricular enlargement investigators
88. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program
89. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure
90. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Inverventions (PEPI) Trial
91. Sex bias in considering coronary by-pass surgery
92. Effects of gender and race on prognosis after myocardial infarction: Adverse prognosis for women, particularly black women
93. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction
94. Effects of raloxifene on serum lipids and coagulation factors in postmenopausal women
95. Treatment of hyperlipidemia in women
96. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study
97. Effect of modest weight loss on changes in cardiovascular risk factors: Are there differences between men and women or between weight loss and maintenance?